ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GnRH Receptor Antagonists Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13F8945
Home | Market Reports | Health| Reproductive Health
Global GnRH Receptor Antagonists Market Outlook 2022
BUY CHAPTERS

Global GnRH Receptor Antagonists Market Research Report 2025

Code: QYRE-Auto-13F8945
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Takeda
Astellas
Kissei
Veru Inc.
Myovant Sciences
Astrazeneca plc
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co

GnRH Receptor Antagonists Market

The global market for GnRH Receptor Antagonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
GnRH antagonists are synthetic analogs of GnRH that bind to the GnRH receptors in the pituitary, rapidly suppressing the secretion of gonadotropins.
North American market for GnRH Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GnRH Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GnRH Receptor Antagonists include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GnRH Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GnRH Receptor Antagonists.
The GnRH Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GnRH Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GnRH Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GnRH Receptor Antagonists Market Report

Report Metric Details
Report Name GnRH Receptor Antagonists Market
Segment by Type
  • Peptides
  • Small Molecules
Segment by Application
  • Prostate Cancer
  • Endometriosis
  • Uterine Fibroids
  • Female Infertility
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GnRH Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GnRH Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the GnRH Receptor Antagonists Market report?

Ans: The main players in the GnRH Receptor Antagonists Market are AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co

What are the Application segmentation covered in the GnRH Receptor Antagonists Market report?

Ans: The Applications covered in the GnRH Receptor Antagonists Market report are Prostate Cancer, Endometriosis, Uterine Fibroids, Female Infertility, Others

What are the Type segmentation covered in the GnRH Receptor Antagonists Market report?

Ans: The Types covered in the GnRH Receptor Antagonists Market report are Peptides, Small Molecules

1 GnRH Receptor Antagonists Market Overview
1.1 Product Definition
1.2 GnRH Receptor Antagonists by Type
1.2.1 Global GnRH Receptor Antagonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Peptides
1.2.3 Small Molecules
1.3 GnRH Receptor Antagonists by Application
1.3.1 Global GnRH Receptor Antagonists Market Value by Application (2024 VS 2031)
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Global GnRH Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global GnRH Receptor Antagonists Revenue 2020-2031
1.4.2 Global GnRH Receptor Antagonists Sales 2020-2031
1.4.3 Global GnRH Receptor Antagonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GnRH Receptor Antagonists Market Competition by Manufacturers
2.1 Global GnRH Receptor Antagonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global GnRH Receptor Antagonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GnRH Receptor Antagonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GnRH Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GnRH Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GnRH Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of GnRH Receptor Antagonists, Date of Enter into This Industry
2.8 Global GnRH Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global GnRH Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GnRH Receptor Antagonists Players Market Share by Revenue
2.8.3 Global GnRH Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GnRH Receptor Antagonists Market Scenario by Region
3.1 Global GnRH Receptor Antagonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GnRH Receptor Antagonists Sales by Region: 2020-2031
3.2.1 Global GnRH Receptor Antagonists Sales by Region: 2020-2025
3.2.2 Global GnRH Receptor Antagonists Sales by Region: 2026-2031
3.3 Global GnRH Receptor Antagonists Revenue by Region: 2020-2031
3.3.1 Global GnRH Receptor Antagonists Revenue by Region: 2020-2025
3.3.2 Global GnRH Receptor Antagonists Revenue by Region: 2026-2031
3.4 North America GnRH Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America GnRH Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GnRH Receptor Antagonists Sales by Country (2020-2031)
3.4.3 North America GnRH Receptor Antagonists Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GnRH Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe GnRH Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GnRH Receptor Antagonists Sales by Country (2020-2031)
3.5.3 Europe GnRH Receptor Antagonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GnRH Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific GnRH Receptor Antagonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GnRH Receptor Antagonists Sales by Region (2020-2031)
3.6.3 Asia Pacific GnRH Receptor Antagonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America GnRH Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America GnRH Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GnRH Receptor Antagonists Sales by Country (2020-2031)
3.7.3 Latin America GnRH Receptor Antagonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GnRH Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa GnRH Receptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GnRH Receptor Antagonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa GnRH Receptor Antagonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GnRH Receptor Antagonists Sales by Type (2020-2031)
4.1.1 Global GnRH Receptor Antagonists Sales by Type (2020-2025)
4.1.2 Global GnRH Receptor Antagonists Sales by Type (2026-2031)
4.1.3 Global GnRH Receptor Antagonists Sales Market Share by Type (2020-2031)
4.2 Global GnRH Receptor Antagonists Revenue by Type (2020-2031)
4.2.1 Global GnRH Receptor Antagonists Revenue by Type (2020-2025)
4.2.2 Global GnRH Receptor Antagonists Revenue by Type (2026-2031)
4.2.3 Global GnRH Receptor Antagonists Revenue Market Share by Type (2020-2031)
4.3 Global GnRH Receptor Antagonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global GnRH Receptor Antagonists Sales by Application (2020-2031)
5.1.1 Global GnRH Receptor Antagonists Sales by Application (2020-2025)
5.1.2 Global GnRH Receptor Antagonists Sales by Application (2026-2031)
5.1.3 Global GnRH Receptor Antagonists Sales Market Share by Application (2020-2031)
5.2 Global GnRH Receptor Antagonists Revenue by Application (2020-2031)
5.2.1 Global GnRH Receptor Antagonists Revenue by Application (2020-2025)
5.2.2 Global GnRH Receptor Antagonists Revenue by Application (2026-2031)
5.2.3 Global GnRH Receptor Antagonists Revenue Market Share by Application (2020-2031)
5.3 Global GnRH Receptor Antagonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie GnRH Receptor Antagonists Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda GnRH Receptor Antagonists Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Astellas
6.3.1 Astellas Company Information
6.3.2 Astellas Description and Business Overview
6.3.3 Astellas GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astellas GnRH Receptor Antagonists Product Portfolio
6.3.5 Astellas Recent Developments/Updates
6.4 Kissei
6.4.1 Kissei Company Information
6.4.2 Kissei Description and Business Overview
6.4.3 Kissei GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kissei GnRH Receptor Antagonists Product Portfolio
6.4.5 Kissei Recent Developments/Updates
6.5 Veru Inc
6.5.1 Veru Inc Company Information
6.5.2 Veru Inc Description and Business Overview
6.5.3 Veru Inc GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Veru Inc GnRH Receptor Antagonists Product Portfolio
6.5.5 Veru Inc Recent Developments/Updates
6.6 Myovant Sciences
6.6.1 Myovant Sciences Company Information
6.6.2 Myovant Sciences Description and Business Overview
6.6.3 Myovant Sciences GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Myovant Sciences GnRH Receptor Antagonists Product Portfolio
6.6.5 Myovant Sciences Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca GnRH Receptor Antagonists Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Ferring Pharmaceuticals
6.8.1 Ferring Pharmaceuticals Company Information
6.8.2 Ferring Pharmaceuticals Description and Business Overview
6.8.3 Ferring Pharmaceuticals GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ferring Pharmaceuticals GnRH Receptor Antagonists Product Portfolio
6.8.5 Ferring Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine Co
6.9.1 Jiangsu Hengrui Medicine Co Company Information
6.9.2 Jiangsu Hengrui Medicine Co Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GnRH Receptor Antagonists Industry Chain Analysis
7.2 GnRH Receptor Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GnRH Receptor Antagonists Production Mode & Process Analysis
7.4 GnRH Receptor Antagonists Sales and Marketing
7.4.1 GnRH Receptor Antagonists Sales Channels
7.4.2 GnRH Receptor Antagonists Distributors
7.5 GnRH Receptor Antagonists Customer Analysis
8 GnRH Receptor Antagonists Market Dynamics
8.1 GnRH Receptor Antagonists Industry Trends
8.2 GnRH Receptor Antagonists Market Drivers
8.3 GnRH Receptor Antagonists Market Challenges
8.4 GnRH Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Takeda
Astellas
Kissei
Veru Inc.
Myovant Sciences
Astrazeneca plc
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
List of Tables
 Table 1. Global GnRH Receptor Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GnRH Receptor Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GnRH Receptor Antagonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GnRH Receptor Antagonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GnRH Receptor Antagonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GnRH Receptor Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GnRH Receptor Antagonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GnRH Receptor Antagonists Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GnRH Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GnRH Receptor Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GnRH Receptor Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of GnRH Receptor Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GnRH Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GnRH Receptor Antagonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GnRH Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GnRH Receptor Antagonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global GnRH Receptor Antagonists Sales Market Share by Region (2020-2025)
 Table 19. Global GnRH Receptor Antagonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global GnRH Receptor Antagonists Sales Market Share by Region (2026-2031)
 Table 21. Global GnRH Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GnRH Receptor Antagonists Revenue Market Share by Region (2020-2025)
 Table 23. Global GnRH Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GnRH Receptor Antagonists Revenue Market Share by Region (2026-2031)
 Table 25. North America GnRH Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GnRH Receptor Antagonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America GnRH Receptor Antagonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America GnRH Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GnRH Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GnRH Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GnRH Receptor Antagonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GnRH Receptor Antagonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GnRH Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GnRH Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GnRH Receptor Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GnRH Receptor Antagonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GnRH Receptor Antagonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GnRH Receptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GnRH Receptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GnRH Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GnRH Receptor Antagonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GnRH Receptor Antagonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GnRH Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GnRH Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GnRH Receptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GnRH Receptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GnRH Receptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GnRH Receptor Antagonists Sales (K Units) by Type (2020-2025)
 Table 51. Global GnRH Receptor Antagonists Sales (K Units) by Type (2026-2031)
 Table 52. Global GnRH Receptor Antagonists Sales Market Share by Type (2020-2025)
 Table 53. Global GnRH Receptor Antagonists Sales Market Share by Type (2026-2031)
 Table 54. Global GnRH Receptor Antagonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GnRH Receptor Antagonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GnRH Receptor Antagonists Revenue Market Share by Type (2020-2025)
 Table 57. Global GnRH Receptor Antagonists Revenue Market Share by Type (2026-2031)
 Table 58. Global GnRH Receptor Antagonists Price (USD/Unit) by Type (2020-2025)
 Table 59. Global GnRH Receptor Antagonists Price (USD/Unit) by Type (2026-2031)
 Table 60. Global GnRH Receptor Antagonists Sales (K Units) by Application (2020-2025)
 Table 61. Global GnRH Receptor Antagonists Sales (K Units) by Application (2026-2031)
 Table 62. Global GnRH Receptor Antagonists Sales Market Share by Application (2020-2025)
 Table 63. Global GnRH Receptor Antagonists Sales Market Share by Application (2026-2031)
 Table 64. Global GnRH Receptor Antagonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GnRH Receptor Antagonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GnRH Receptor Antagonists Revenue Market Share by Application (2020-2025)
 Table 67. Global GnRH Receptor Antagonists Revenue Market Share by Application (2026-2031)
 Table 68. Global GnRH Receptor Antagonists Price (USD/Unit) by Application (2020-2025)
 Table 69. Global GnRH Receptor Antagonists Price (USD/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie GnRH Receptor Antagonists Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Takeda Company Information
 Table 76. Takeda Description and Business Overview
 Table 77. Takeda GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Takeda GnRH Receptor Antagonists Product
 Table 79. Takeda Recent Developments/Updates
 Table 80. Astellas Company Information
 Table 81. Astellas Description and Business Overview
 Table 82. Astellas GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Astellas GnRH Receptor Antagonists Product
 Table 84. Astellas Recent Developments/Updates
 Table 85. Kissei Company Information
 Table 86. Kissei Description and Business Overview
 Table 87. Kissei GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Kissei GnRH Receptor Antagonists Product
 Table 89. Kissei Recent Developments/Updates
 Table 90. Veru Inc Company Information
 Table 91. Veru Inc Description and Business Overview
 Table 92. Veru Inc GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Veru Inc GnRH Receptor Antagonists Product
 Table 94. Veru Inc Recent Developments/Updates
 Table 95. Myovant Sciences Company Information
 Table 96. Myovant Sciences Description and Business Overview
 Table 97. Myovant Sciences GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Myovant Sciences GnRH Receptor Antagonists Product
 Table 99. Myovant Sciences Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. AstraZeneca GnRH Receptor Antagonists Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. Ferring Pharmaceuticals Company Information
 Table 106. Ferring Pharmaceuticals Description and Business Overview
 Table 107. Ferring Pharmaceuticals GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Ferring Pharmaceuticals GnRH Receptor Antagonists Product
 Table 109. Ferring Pharmaceuticals Recent Developments/Updates
 Table 110. Jiangsu Hengrui Medicine Co Company Information
 Table 111. Jiangsu Hengrui Medicine Co Description and Business Overview
 Table 112. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product
 Table 114. Jiangsu Hengrui Medicine Co Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. GnRH Receptor Antagonists Distributors List
 Table 118. GnRH Receptor Antagonists Customers List
 Table 119. GnRH Receptor Antagonists Market Trends
 Table 120. GnRH Receptor Antagonists Market Drivers
 Table 121. GnRH Receptor Antagonists Market Challenges
 Table 122. GnRH Receptor Antagonists Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GnRH Receptor Antagonists
 Figure 2. Global GnRH Receptor Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GnRH Receptor Antagonists Market Share by Type: 2024 & 2031
 Figure 4. Peptides Product Picture
 Figure 5. Small Molecules Product Picture
 Figure 6. Global GnRH Receptor Antagonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GnRH Receptor Antagonists Market Share by Application: 2024 & 2031
 Figure 8. Prostate Cancer
 Figure 9. Endometriosis
 Figure 10. Uterine Fibroids
 Figure 11. Female Infertility
 Figure 12. Others
 Figure 13. Global GnRH Receptor Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global GnRH Receptor Antagonists Market Size (2020-2031) & (US$ Million)
 Figure 15. Global GnRH Receptor Antagonists Sales (2020-2031) & (K Units)
 Figure 16. Global GnRH Receptor Antagonists Average Price (USD/Unit) & (2020-2031)
 Figure 17. GnRH Receptor Antagonists Report Years Considered
 Figure 18. GnRH Receptor Antagonists Sales Share by Manufacturers in 2024
 Figure 19. Global GnRH Receptor Antagonists Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest GnRH Receptor Antagonists Players: Market Share by Revenue in GnRH Receptor Antagonists in 2024
 Figure 21. GnRH Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global GnRH Receptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America GnRH Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 24. North America GnRH Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 25. United States GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe GnRH Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 28. Europe GnRH Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 29. Germany GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific GnRH Receptor Antagonists Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific GnRH Receptor Antagonists Revenue Market Share by Region (2020-2031)
 Figure 36. China GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America GnRH Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 46. Latin America GnRH Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa GnRH Receptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa GnRH Receptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE GnRH Receptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of GnRH Receptor Antagonists by Type (2020-2031)
 Figure 56. Global Revenue Market Share of GnRH Receptor Antagonists by Type (2020-2031)
 Figure 57. Global GnRH Receptor Antagonists Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of GnRH Receptor Antagonists by Application (2020-2031)
 Figure 59. Global Revenue Market Share of GnRH Receptor Antagonists by Application (2020-2031)
 Figure 60. Global GnRH Receptor Antagonists Price (USD/Unit) by Application (2020-2031)
 Figure 61. GnRH Receptor Antagonists Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global GnRH Analogues Market Research Report 2024
Global GnRH Agonist Market Research Report 2024
Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Leuprorelin Drugs Market Research Report 2024
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Oral GnRH Drugs Market Research Report 2024
Global Gonadorelin Market Insights Forecast to 2030
Global Gonadorelin Acetate Market Insights Forecast to 2030
Global Non injectable GnRH Drugs Market Research Report 2024
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Elagolix Drugs Market Research Report 2024
Global Luteinizing Hormone Releasing Antagonist Market Research Report 2024
Global GnRH Analogue Market Research Report 2024
Global Leuprolide Market Research Report 2024
Global Anti GnRH Antibody Market Research Report 2024
Global GnRHa Peptide Drugs Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions